Literature DB >> 25632209

Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.

Simona Gurzu1, Zoltan Kadar1, Tivadar Bara1, Tivadar Bara1, Adrian Tamasi1, Leonard Azamfirei1, Ioan Jung1.   

Abstract

Mixed adenoneuroendocrine carcinoma (MANEC) is a rare tumor of the gastrointestinal tract that consists of a dual adenocarcinomatous and neuroendocrine differentiation, each component representing at least 30% of the tumor. To date, only seven cases have been reported in the cecum, and less than 40 in the stomach. Our first case was diagnosed in a 74-years-old female as a polypoid lesion of the cecum with direct invasion in the transverse colon, without lymph node metastases. The second case was diagnosed in the stomach of a 46-years-old male as a polypoid tumor of the antral region that invaded the pancreas and presented metastases in 22 regional lymph nodes. The metastatic tissue was represented by the glandular component. In both cases, the tumor consisted of a moderately-differentiated tubular adenocarcinoma (with mucinous component in Case 1) intermingled with neuroendocrine carcinoma. Ki67 index was lower than 20% in Case 1, respectively higher than 20% in Case 2. The neuroendocrine component was marked by synaptophysin and neuron specific enolase, being negative for Keratins 7/20. The neuroendocrine component represented 60% in Case 1, and 40% in Case 2, respectively. The glandular components were marked by carcinoembryonic antigen, maspin and keratin 20/7 (Case 1/2). Both cases were proved to be microsatellite stable. Independently by the localization and tumor stage, MANECs appear to be highly malignant tumors, with high risk for distant metastases. The aggressiveness seems to depend on the endocrine component, independent of its proportion. The neuroendocrine component could be a dedifferentiated adenocarcinoma with a neuroendocrine phenotype.

Entities:  

Keywords:  Carcinoembryonic antigen; Cecum; Colorectal; Composite tumor; Keratin 20; Keratin 7; Maspin; Mixed adenoneuroendocrine carcinoma; Mixed tumor; Stomach

Mesh:

Substances:

Year:  2015        PMID: 25632209      PMCID: PMC4306180          DOI: 10.3748/wjg.v21.i4.1329

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  [Treatment of sequelace of corneal wounds].

Authors:  R Faggioni; E B Streiff
Journal:  Annee Ther Clin Ophtalmol       Date:  1977

2.  Practical value of the new system for Maspin assessment, in colorectal cancer.

Authors:  S Gurzu; Z Szentirmay; D Popa; I Jung
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

3.  Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis.

Authors:  Khalilullah Mia-Jan; Jijgee Munkhdelger; Mi-Ra Lee; Sun-Young Ji; Tae Young Kang; EunHee Choi; Mee-Yon Cho
Journal:  Tohoku J Exp Med       Date:  2013-04       Impact factor: 1.848

4.  Mixed adenoneuroendocrine carcinoma of cecum: a rare entity.

Authors:  Aditi Jain; Saurabh Singla; K S Jagdeesh; H Y Vishnumurthy
Journal:  J Clin Imaging Sci       Date:  2013-02-28

5.  Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.

Authors:  Shi Chen; Jing-Hui Hou; Xing-Yu Feng; Xiao-Shi Zhang; Zhi-Wei Zhou; Jing-Ping Yun; Ying-Bo Chen; Mu-Yan Cai
Journal:  J Surg Oncol       Date:  2013-04-22       Impact factor: 3.454

6.  A gastric composite tumor with an adenocarcinoma and a neuroendocrine carcinoma: a case report.

Authors:  Jae Hyung Lee; Hyung Wook Kim; Dae Hwan Kang; Cheol Woong Choi; Su Bum Park; Suk Hun Kim
Journal:  Clin Endosc       Date:  2013-05-31

7.  Clinicopathologic significance of gastric adenocarcinoma with neuroendocrine features.

Authors:  Jang Jin Kim; June Young Kim; Hoon Hur; Yong Kwan Cho; Sang-Uk Han
Journal:  J Gastric Cancer       Date:  2011-12-29       Impact factor: 3.720

8.  Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma.

Authors:  Fei Zhou; Yin-Dong Mu; Jun Liang; Zhi-Xin Liu; Hong-Sheng Chen; Ji-Fei Zhang
Journal:  Oncol Lett       Date:  2013-12-02       Impact factor: 2.967

9.  Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China.

Authors:  Yu-Hong Wang; Yuan Lin; Ling Xue; Jin-Hui Wang; Min-Hu Chen; Jie Chen
Journal:  BMC Endocr Disord       Date:  2012-11-29       Impact factor: 2.763

10.  Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus.

Authors:  Toshihiro Kitajima; Sachiko Kaida; Seigi Lee; Shusuke Haruta; Hisashi Shinohara; Masaki Ueno; Koichi Suyama; Yasunori Oota; Takeshi Fujii; Harushi Udagawa
Journal:  World J Surg Oncol       Date:  2013-09-04       Impact factor: 2.754

View more
  29 in total

1.  Mixed adenoneuroendocrine carcinoma in the stomach: a case report with a literature review.

Authors:  Ki Hyun Kim; Hyun Jung Lee; Si Hak Lee; Sun-Hwi Hwang
Journal:  Ann Surg Treat Res       Date:  2018-04-30       Impact factor: 1.859

2.  Collision tumour of large-cell neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report.

Authors:  Eduardo Payet; Pau I Pilco; Jaime Montes; Alejandra Cordero-Morales; Maria Jose Savitzky; Karoline Stenning-Persivale
Journal:  Ecancermedicalscience       Date:  2016-01-29

3.  A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component.

Authors:  Hussein Nassereddine; Nicolas Poté; Nathalie Théou-Anton; Gaële Lamoureux; Jean-François Fléjou; Anne Couvelard
Journal:  Virchows Arch       Date:  2017-06-26       Impact factor: 4.064

4.  Long-term disease free survival of gastric mixed adenoneuroendocrine carcinoma treated with multimodality therapy: A case report.

Authors:  Guangjian Yang; Dan Li; Fangchao Zheng; Lin Yang
Journal:  Mol Clin Oncol       Date:  2018-03-26

5.  Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.

Authors:  Takashi Ogimi; Sotaro Sadahiro; Yutaro Kamei; Lin Fung Chan; Hiroshi Miyakita; Gota Saito; Kazutake Okada; Toshiyuki Suzuki; Hiroshi Kajiwara
Journal:  Oncology       Date:  2019-08-07       Impact factor: 2.935

6.  Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.

Authors:  Simona Gurzu; Sabin Turdean; Attila Kovecsi; Anca Otilia Contac; Ioan Jung
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

7.  Perforated High-Grade Mixed Neuroendocrine Nonneuroendocrine Neoplasm of Cecum: Unusual Presentation of Rare Disease.

Authors:  Gunasekaran Gopalakrishnan; Bheemanathi Hanuman Srinivas; Biju Pottakkat; Senthil Gnanasekaran; Raja Kalayarasan
Journal:  Gastrointest Tumors       Date:  2021-04-20

8.  Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: A case report.

Authors:  Nicole Max; Alexander Rothe; Cord Langner
Journal:  Mol Clin Oncol       Date:  2016-04-14

9.  Mixed acinar-neuroendocrine-ductal carcinoma of the pancreas: a tale of three lineages.

Authors:  Mark J Anderson; Christina A Kwong; Mohammed Atieh; Sam G Pappas
Journal:  BMJ Case Rep       Date:  2016-06-02

10.  Management of MANEC of the colon and rectum: A comprehensive review of the literature.

Authors:  Anna Paspala; Nikolaos Machairas; Anastasia Prodromidou; Eleftherios Spartalis; Argyrios Ioannidis; Ioannis D Kostakis; Dimetrios Papaconstantinou; Nikolaos Nikiteas
Journal:  Mol Clin Oncol       Date:  2018-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.